Prokaryotics
- John Tomayko
Dr. Tomayko is Vice President of Clinical Development at F2G, and is an expert in the Clinical Development of antibiotics with extensive experience in industry in key roles at Pfizer, Spero and GSK.
Prokaryotics
Dr. Tomayko is Vice President of Clinical Development at F2G, and is an expert in the Clinical Development of antibiotics with extensive experience in industry in key roles at Pfizer, Spero and GSK.